Devyser Diagnostics Q4: A robust quarter for the overlooked high-performer
Research Update
2023-02-22
15:07
Redeye is positive to Devyser’s Q4 report as the company continues to deliver well on its key metrics and demonstrates a progress in line with its financial targets. Sales came in line, and OPEX was overall in check compared to our estimates. We lower our WACC based on a review of Redeye Quality Rating and update our fair value range accordingly.
OB
Oscar Bergman
Disclosures and disclaimers